Differentiating sepsis from non-infectious systemic inflammation based on microvesicle-bacteria aggregation.
I K Herrmann, S Bertazzo, D J P O'Callaghan, A A Schlegel, C Kallepitis, D B Antcliffe, A C Gordon, M M Stevens
Index: Nanoscale 7 , 13511-20, (2015)
Full Text: HTML
Abstract
Sepsis is a severe medical condition and a leading cause of hospital mortality. Prompt diagnosis and early treatment has a significant, positive impact on patient outcome. However, sepsis is not always easy to diagnose, especially in critically ill patients. Here, we present a conceptionally new approach for the rapid diagnostic differentiation of sepsis from non-septic intensive care unit patients. Using advanced microscopy and spectroscopy techniques, we measure infection-specific changes in the activity of nano-sized cell-derived microvesicles to bind bacteria. We report on the use of a point-of-care-compatible microfluidic chip to measure microvesicle-bacteria aggregation and demonstrate rapid (≤1.5 hour) and reliable diagnostic differentiation of bacterial infection from non-infectious inflammation in a double-blind pilot study. Our study demonstrates the potential of microvesicle activities for sepsis diagnosis and introduces microvesicle-bacteria aggregation as a potentially useful parameter for making early clinical management decisions.
Related Compounds
Related Articles:
2015-03-15
[Cancer Res. 75(6) , 1102-12, (2015)]
Aptamer-based polyvalent ligands for regulated cell attachment on the hydrogel surface.
2015-04-13
[Biomacromolecules 16(4) , 1382-9, (2015)]
2015-04-22
[J. Ethnopharmacol. 164 , 265-72, (2015)]
2015-01-01
[Bioresour. Technol. 176 , 156-62, (2014)]
Polymerization of affinity ligands on a surface for enhanced ligand display and cell binding.
2014-12-08
[Biomacromolecules 15(12) , 4561-9, (2014)]